Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China

Microbial Drug Resistance

Volumn 14, Issue 3, 2008, Pages 227-232

  Hu, Yi ^a   Mathema, Barun ^b   Wang, Weibing ^a   Hoffner, Sven ^c   Kreiswirth, Barry ^b   Xu, Biao ^a  

^a FUDAN UNIVERSITY   (China)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CHINA; CONTROLLED STUDY; HEALTH CARE SYSTEM; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SHORT COURSE THERAPY; SPUTUM ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTITUBERCULAR AGENTS; CHINA; CROSS-SECTIONAL STUDIES; DIRECTLY OBSERVED THERAPY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RURAL POPULATION; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 51349129663     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0823     Document Type: Article

References (29)

1. Aziz, M.A., A. Wright, A. Laszlo, A. de Muynck, F. Portaels, A. van Deun, C. Wells, P. Nunn, L. Blanc, and M. Ravilglione. 2006. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-Tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 368:2142-2154.
2. Canetti, G., S. Frman, J. Grosset, P. Hauduroy, M. Langerova, H.T. Mahler, G. Meissner, D.A. Mitchison, and L. Sula. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. World Health Organ. 29:565-578.
3. Cardoso, E.M. 2004. Multiple drug resistance: a threat for tuberculosis control. Rev. Panam. Salud Publica 16:68-73.
4. Crofton, J., P. Chaulet, and D. Maher. 1997. Guidelines for the management of drug-resistant tuberculosis. Publication No. WHO/TB96.210 (Rev.1) Geneva. World Health Organization, Geneva, pp. 73-85.
5. de Melo, F.A., J.B. Afiune, J. Ide Neto, E.A. de Almeida, D.T. Spada, A.N. Antelmo, and M.L. Cruz. 2003. Epidemiological features of multidrug-resistant tuberculosis in a reference service in Sao Paulo city. Rev. Soc. Bras. Med. Trop. 26:27-34.
6. Espinal, M.A., S.J. Kim, P.G. Suarez, K.M. Kam, A.G. Khomenko, G.B. Migliori, J. Baez, A. Kochi, C. Dye, and M.C. Raviglione. 2000. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcome in 6 countries. JAMA 283:2537-2545.
7. Espinal, M.A., K. Laserson, M. Camacho, Z. Fusheng, S.J. Kim, R.E. Tlali, I. Smith, P. Suarez, M.L. Antunes, A.G. George, M. Martin-Casabona, P. Simelane, K. Weyer, N. Binkin, and M.C. Raviglione. 2001. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int. J. Tuberc. Lung Dis. 10:887-893.
8. Gao, C.N. 2002. Study on compliance with regular treatment for pulmonary TB. J. Chin. Antituberc. Assoc. 24:273-274.
9. Hane, F., S. Thiam, A.S. Fall, L. Vidal, A.H. Diop, M. Ndir, and C. Lienhardt. 2007. Identifying barriers to effective tuberculosis control in Senegal: an anthropological approach. Int. J. Tuberc. Lung Dis. 11:539-543.
10. Harries, A.D., D. Maher, and S. Graham. 1996. Diagnosis of pulmonary tuberculosis in adults. In TB/HIV - a clinical manual. First edition. World Health Organization, Geneva, pp. 25-44.
11. Hu, Q.F. 2000. The analysis on the causes of 105 tuberculosis case with drug resistance TB health education. J. Chin. Antituberc. Assoc. 2:65-66.
12. Lee, J.H., and J.H. Chang. 2001. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J. Intern. Med. 16:173-179.
13. Li, A.X., Y.Y. Wang, Y.L. Wang, and Z.H.W. Xia. 2003. Investigation on the factors of compliance that affect the treatment of TB. Occup. Health 8:135-136.
14. Ministry of Health. 1999. Detection of tuberculosis cases. In National workbook of TB control. Ministry of Health, Beijing, pp. 25-27.
15. Ministry of health, China. 2002. Report on national wide random survey for the epidemiology of tuberculosis in 2000. J. Chin. Antituberc. Assoc. 24:65-107.
16. National Bureau of Statistics of PRC. 2004. People's lives. In D.S. Li (ed.), China statistical yearbook 2004. China Statistics Press, Beijing, pp. 148-149.
17. Pabolos-Mendez, A., A. Lazlo, and F. Bustreo. 1997. Anti-tuberculosis drug resistance in the world. Publication No. WHO/GTP/229. World Health Organization, Geneva. Global Tuberculosis Programme, 76.
18. Sharma, S.K., K.K. Turaga, A. Balamurugan, P.K. Saha, R.M. Pandey, N.K. Jain, V.M. Katoch, and N.K. Mehra. 2003. Clinical and genetic risk factors for the development of multidrug-resistant tuberculosis in non-HIV infected at a tertiary care center in India: a case-control study. Infect. Genet. Evol. 3:183-188.
19. Wang, G.J., J.Y. Xu, G.B. Wang, X.A. Zhen, S.Y. Gao, and C.M. Du. 2006. Impact of anti-tuberculosis drug resistant on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province. Zhonghua Jie He Hu Xi Za Zhi 29:527-530.
20. Wang, H., Y.S. Yu, Y. Liu, H.Y. Li, B.J. Hu, Z.Y. Sun, and M.J. Chen. 2004. Resistance surveillance of common community respiratory pathogens isolated in China, 2002-2003. Zhonghua Jie He Hu Xi Za Zhi 27:155-160.
21. Wang, L., J. Liu, and D.P. Chin. 2007. Progress in tuberculosis control and the evolving public-health system in China. Lancet 369:691-696.
22. WHO. 2007. Global tuberculosis control: surveillance, planning, financing. WHO report Geneva, World Health Organization (WHO/HTM/TB/2007.376).
23. Xianyi, C., Z. Fengzeng, D. Hongjin, W. Liya, W. Lixia, D. Xin, and D.P. Chin. 2002. The DOTS strategy in China: results and lessons after 10 years. Bull. World Health Organ. 80:430-436.
24. Xu, B., H.J. Dong, Q. Zhao, and L. Bogg. 2006. DOTS in China - removing barriers or moving barriers? Health Policy Plan 21:365-372.
25. Xu, B., G. Fochsen, and Y. Xiu. 2004. Perceptions and experiences of health care seeking and access to TB care - a qualitative study in rural Jiangsu Province. China Health Policy 69:134-149.
26. Xu, B., Q.W. Jiang, Y. Xiu, and V.K. Diwan. 2005. Diagnostic delays in access to tuberculosis care in counties with or without National Tuberculosis Control Program in rural China. Int. J. Tuberc. Lung Dis. 97:784-790.
27. Yang, B.F., B. Xu, W.L. Jiang, P.Y. Zhou, and Q.W. Jiang. 2004. Study on the epidemiology and determinants of drug-resistant tuberculosis in northern rural area of Jiangsu Province. Zhonghua Liu Xing Bing Xue Za Zhi 25:582-585.
28. Zhao, Q., B. Xu, and Y. Xiu. 2003. Knowledge and practice about tuberculosis control and management among Grass-roots Medical workers in Jiangsu Province. Chin. Health Educ. 19:835-837.
29. Zignol, M., M.S. Hosseini, A. Wright, C.L. Weezenbeek, P. Nunn, C.J. Watt, B.G. Williams, and C. Dye. 2006. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 194:479-485.